Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

NCT02045056 is registered in ClinicalTrials.gov with Gregory Jicha, 323-5550 as lead sponsor.

NCT NCT02045056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02045056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Lead sponsor
Gregory Jicha, 323-5550
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2014
Completion date
June 30, 2019
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preclinical alzheimer's disease